Fluorescent oxidation products and risk of coronary heart disease: A prospective study in women

Journal of the American Heart Association

Volumn 2, Issue 5, 2013, Pages

  Jensen, Majken K ^a   Wang, Yushan ^c   Rimm, Eric B ^a,b   Townsend, Mary K ^b   Willett, Walter ^a   Wu, Tianying ^b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

Follow up studies; Myocardial infarction; Oxidative stress; Risk factors; women

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FLUORESCENT OXIDATION PRODUCT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; OXIDATIVE STRESS; PROSPECTIVE STUDY; SMOKING; SPECTROFLUOROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FLUORESCENCE; HEART INFARCTION; METABOLISM; MIDDLE AGED; RISK; RISK FACTOR;

FOLLOW-UP STUDIES; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RISK FACTORS; WOMEN;

CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; FLUORESCENCE; HUMANS; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RISK;

EID: 84885294319     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.113.000195     Document Type: Article

References (20)

1. Gross M, Steffes M, Jacobs DR Jr, Yu X, Lewis L, Lewis CE, Loria CM. Plasma F2-isoprostanes and coronary artery calcification: the CARDIA study. Clin Chem. 2005;51:125-131.
2. Schwedhelm E, Bartling A, Lenzen H, Tsikas D, Maas R, Brummer J, Gutzki FM, Berger J, Frolich JC, Boger RH. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation. 2004;109:843-848.
3. Shishehbor MH, Zhang R, Medina H, Brennan ML, Brennan DM, Ellis SG, Topol EJ, Hazen SL. Systemic elevations of free radical oxidation products of arachidonic acid are associated with angiographic evidence of coronary artery disease. Free Radical Biol Med. 2006;41:1678-1683.
4. Woodward M, Croft KD, Mori TA, Headlam H, Wang XS, Suarna C, Raftery MJ, MacMahon SW, Stocker R. Association between both lipid and protein oxidation and the risk of fatal or non-fatal coronary heart disease in a human population. Clin Sci (Lond). 2009;116:53-60.
5. Wu T, Rifai N, Willett WC, Rimm EB. Plasma fluorescent oxidation products: independent predictors of coronary heart disease in men. Am J Epidemiol. 2007;166:544-551.
6. Frankel EN. Lipid Oxidation. 2nd ed. Dundee, Scotland: The Oily Press Ltd; 2005.
7. Wu T, Willett WC, Rifai N, Rimm EB. Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies. Am J Epidemiol. 2007;166:552-560.
8. Wu T, Rifai N, Roberts LJ II, Willett WC, Rimm EB. Stability of measurements of biomarkers of oxidative stress in blood over 36 hours. Cancer Epidemiol Biomarkers Prev. 2004;13:1399-1402.
9. Rebholz CM, Wu T, Hamm LL, Arora R, Khan IE, Liu Y, Chen CS, Mills KT, Rogers S, Kleinpeter MA, Simon EE, Chen J. The association of plasma fluorescent oxidation products and chronic kidney disease: a case-control study. Am J Nephrol. 2012;36:297-304.
10. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6:49-62.
11. Prentice RL, Breslow NE. Retrospective studies and failure time models. Biometrika. 1978;65:153-158.
12. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135:1114-1126; discussion 1127-1136.
13. Frankel EN, Neff WE, Brooks DD, Fujimoto K. Fluorescence formation from the interaction of DNA with lipid oxidation degradation products. Biochim Biophys Acta. 1987;919:239-244.
14. Fujimoto K, Neff WE, Frankel EN. The reaction of DNA with lipid oxidation products, metals and reducing agents. Biochim Biophys Acta. 1984;795:100-107.
15. Flynn TP, Allen DW, Johnson GJ, White JG. Oxidant damage of the lipids and proteins of the erythrocyte membranes in unstable hemoglobin disease. Evidence for the role of lipid peroxidation. J Clin Investig. 1983;71: 1215-1223.
16. Polidori MC, Cherubini A, Stahl W, Senin U, Sies H, Mecocci P. Plasma carotenoid and malondialdehyde levels in ischemic stroke patients: relationship to early outcome. Free Radical Res. 2002;36:265-268.
17. Susa T, Kobayashi S, Tanaka T, Murakami W, Akashi S, Kunitsugu I, Okuda S, Doi M, Wada Y, Nao T, Yamada J, Ueyama T, Okamura T, Yano M, Matsuzaki M. Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure. Circ J. 2012;76:117-126.
18. Mezzetti A, Zuliani G, Romano F, Costantini F, Pierdomenico SD, Cuccurullo F, Fellin R. Vitamin E and lipid peroxide plasma levels predict the risk of cardiovascular events in a group of healthy very old people. J Am Geriatr Soc. 2001;49:533-537.
19. Ross R, Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med. 1976;295:420-425.
20. Burgoyne JR, Mongue-Din H, Eaton P, Shah AM. Redox signaling in cardiac physiology and pathology. Circ Res. 2012;111:1091-1106.